Patented and GSA approved, the iCleanse family of products effectively kills pathogens that can lead to infection in as little as 15 seconds.
iCleanse Swift & Swift Mini
| Organism Tested | ID | Time (in seconds) | Notes | Log Reduction vs Control | Efficacy Results | Lab |
| MRSA | ATCC 33591 | 15 | >4.98 | 100.00% | ResInnova | |
| OC43 (Human Coronavirus) | 15 | >2.98 | 99.90% | ResInnova |
iCleanse Swift XL
| Organism Tested | ID | Time (in seconds) | Notes | Log Reduction vs Control | Efficacy Results | Lab |
| MRSA | Clinical Strain | 30 | >6.13 | 100.00% | ResInnova | |
| VRE | Clinical Strain | 30 | >6 | 100.00% | UCONN | |
| C. Diff | ATCC 70057 | 120 | Toxinotype tcdA-, tcdB- Ribotype 038 Binary toxin gene cdtB not amplified by PCR Nontoxigenic |
1.2 – > 2.2 | 90% – 99.99% | YNHH |
| OC43 (Human Coronavirus) | 30 | >3.5 | 100.00% | ResInnova |
iCleanse Swift 5x
| Organism Tested | ID | Time (in seconds) | Notes | Log Reduction vs Control | Efficacy Results | Lab |
| Enterococcus faecium | ATCC 51559 | 60 | Multidrug-resistant (ampicillin, ciprofoxacin, gentamicin, rifampin, teicoplanin, and vancomycin) Presence of VanAgene confirmed by PCR. |
>4 | 99.90% | YNHH |
| Staphylococcus aureus subsp. Aureus (MRSA) |
ATCC 43300 | 60 | Resistant to methicillin, Resistant to oxacillin.Absence of PVL gene confirmed by PCR. MRSA SCCmec: Type II spa type: Ridom: t007 spa type Kreiswirth: WGKKKKAOM pvl gene amplification: Negative |
>4.5 | 100.00% | YNHH |
| Pseudomonas aeruginosa | ATCC 27853 | 60 | Effect of salt concentration on gentamicin susceptibility | >6 | 100.00% | YNHH |
| Acinetobacter baumannii | ATCC BAA747 | 60 | Vitek #109234 [API 8310086, NSB 4221] | >6 | 100.00% | YNHH |
| Salmonella | Clinical Strain | 60 | >5 | 99.90% | YNHH | |
| C.Diff | ATCC 70057 | 120 | Toxinotype tcdA-, tcdB- Ribotype 038 Binary toxin gene cdtB not amplified by PCR Nontoxigenic |
1 – > 3 | 90% – 99.90% | YNHH |
Results are based on tests of our devices in a laboratory setting and are not meant to expand the claim of iCleanse’s ability to provide general-purpose disinfection to mobile devices.
- The devices were inoculated and then processed in the iCleanse without any pre-cleaning.
- The process for C.Diff was by serial dilution (spores) & subsequent culture not ATP.
- Pre-cleaning will reduce the bio-burden before disinfecting and produce even better results.
- The disinfection time can be changed based on your preferences by accessing the settings menu on your unit (refer to user manual).
- Remember, iCleanse provides an engineering control (automated, reproducible process) for disinfection, executing the same method in the same manner without relying on the variability of a user’s compliance to the protocol, affording the reduction or elimination of human error.